Metis TechBio Co., Ltd. Class H's next confirmed earnings release is scheduled for March 3, 2027.
| Earnings Date | 3/3/2027 |
As of December 31, 2025, Metis TechBio Co., Ltd. Class H has 1.15B shares outstanding.
| Shares Outstanding | 1.15B |
As of December 31, 2025, Metis TechBio Co., Ltd. Class H maintains a current ratio of 6.67, meaning it holds 6.7x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 6.67 |
| Quick Ratio | 6.54 |
| Debt / Equity | 12.60 |
Over the twelve months ended December 31, 2025, Metis TechBio Co., Ltd. Class H recorded 127,982.44 in income tax expense.
| Income Tax | 127,982.44 |
These figures are as of the close on October 23, 2026.
| 50-Day Moving Average | 14.43 |
As of December 31, 2025, Metis TechBio Co., Ltd. Class H holds 1.25B in cash and equivalents against 145.93M in total debt, resulting in a net debt position of -877.25M. Total book value stands at 1.16B, with working capital of 1.09B providing operational flexibility.
| Cash & Cash Equivalents | 1.25B |
| Total Debt | 145.93M |
| Net Debt | -877.25M |
| Equity (Book Value) | 1.16B |
| Book Value Per Share | 1.01 |
| Working Capital | 1.09B |
These figures cover the twelve months ended December 31, 2025.
| Capital Expenditures | -7.12M |
Already premium?